You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
The effort aims to screen for SARS-CoV-2 in the San Diego community and study the virus' genome to better understand how it is transmitted.
Though it is unclear whether the virus became pathogenic before or after the jump from animals to humans, genomic features point to a natural source for the COVID-19 coronavirus.
The US Court of Appeals for the Federal Circuit affirmed a lower-court decision in favor of Illumina, which Scripps had sued over marketing of bead-based microarrays.
Researchers saw signs of an unreported Zika virus outbreak in Cuba in 2017, well after the documented decline in new cases in Brazil and other parts of the world.
ScienceInsider reports Floyd Romesberg has been forced out from the Scripps Research Institute.
In PNAS this week: role for exosomes in neuronal circuit development, tuberculosis pathogen enzymes, and more.
An analysis of B cell adaptive immune receptor sequences in 10 individuals uncovered exceptionally diverse antibody repertoires with a subset of shared antibody clonotypes.
The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.
There are some deep divisions between the three main databases, some due to competitive pressures and others because of the nature of metabolomics.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.